@article{oai:repo.qst.go.jp:00046748,
 author = {Wakatuki, Masaru and Kato, Shingo and Karasawa, Kumiko and Tsujii, Hirohiko and Kamada, Tadashi and 若月 優 and 加藤 眞吾 and 唐澤 久美子 and 辻井 博彦 and 鎌田 正},
 journal = {iConcept Press},
 month = {Jan},
 note = {This Heavy charged particle radiation therapy for cancer treatment started at the National Institute of R Heavy charged particle radiation therapy for cancer treatment started at the National Institute of Radiological Sciences in June
1994 using carbon ions that were generated by the heavyion medical a
celerator in Chiba, where all patients have been treated within prospective Phase I/II or Phase II studies.
Carbon ion beams have improved the properties of dose localization, a potentiality that can produce great effects on tumors while minimizing normal tissue damage. Moreover, they possess a biological advantage due to their high relative biological effectiveness (RBE) in the Bragg Peak. Since 1994, more than 7000 patients have been treated with carbonion radiation therapy (C-ion RT), demonstrating the benefit of C-ion RT over other modalities for various types of tumors in terms of high local control and survival rates(Tsujii & Kamada, 2012).},
 title = {A Review of Update Clinical Results of Carbon Ion Radiotherapy for Uterine Cervical Cancer},
 volume = {1},
 year = {2014}
}